SREBF1 and diabetes mellitus: The expression levels of SREBP-1 and fatty acid synthase (FAS) increase in a rat model of streptozotocin-induced diabetes mellitus and murine cortical tubule cells treated with high glucose, resulting in increased triglyceride accumulation30.